{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Derivative use, Inverse exposure, Daily reset compounding, Complex index exposure",
    "classification": "complex",
    "supporting_data": "The product is a WisdomTree EURO STOXX Banks 3x Daily Short ETP, which is a UCITS eligible Exchange Traded Product but not a plain UCITS ETF. It provides leveraged short exposure (-3x daily) to the EURO STOXX Banks index, using derivatives to achieve this leverage and inverse exposure. The product uses synthetic replication through futures contracts and derivatives, which introduces counterparty and collateral risks that are difficult for retail investors to understand. The daily reset of leverage causes compounding effects, making the return over periods longer than one day deviate significantly from the simple multiple of the index return, adding complexity. The product is classified as a collateralised debt security (ETP), not a straightforward ETF, and it explicitly carries a highest risk rating (7/7), reflecting high volatility and risk of total loss. The product documentation includes a comprehension alert stating it is 'not simple and may be difficult to understand,' confirming its complex nature. According to MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, UCITS ETFs are presumed non-complex unless they embed derivatives integral to the strategy, use synthetic replication, or have leverage beyond UCITS limits. This product uses derivatives centrally, synthetic replication, and significant leverage (3x short), all of which are complexity factors. The product does not have capital protection and involves risks such as counterparty risk, collateral risk, and complex payoff profiles due to leverage and inverse exposure. Therefore, it fails the criteria for non-complex instruments under Article 57, including exclusion from derivatives (Art 4(1)(44)(c)), frequent opportunities to dispose at transparent prices (due to complexity and leverage), no excess liability (leverage implies potential losses beyond initial investment), and comprehensive understandable information (the product is complex and requires advanced knowledge). Hence, the product is classified as complex under MiFID II and requires an appropriateness assessment before sale to retail investors."
}